FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.83 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,093,000 | -36.9% | 135,195 | -71.5% | 0.00% | -50.0% |
| Q4 2020 | $8,077,000 | +908.4% | 474,854 | +178.8% | 0.00% | – |
| Q3 2020 | $801,000 | +191.3% | 170,297 | +277.7% | 0.00% | – |
| Q2 2020 | $275,000 | +261.8% | 45,084 | +35.6% | 0.00% | – |
| Q1 2020 | $76,000 | -42.0% | 33,257 | +16.4% | 0.00% | – |
| Q4 2019 | $131,000 | -52.9% | 28,572 | -60.2% | 0.00% | – |
| Q3 2019 | $278,000 | -41.8% | 71,782 | -9.4% | 0.00% | – |
| Q2 2019 | $478,000 | -63.2% | 79,235 | -18.2% | 0.00% | – |
| Q1 2019 | $1,298,000 | +49.5% | 96,908 | +3.8% | 0.00% | – |
| Q4 2018 | $868,000 | -72.7% | 93,376 | -59.1% | 0.00% | -100.0% |
| Q3 2018 | $3,178,000 | -16.6% | 228,354 | -5.3% | 0.00% | 0.0% |
| Q2 2018 | $3,812,000 | -6.1% | 241,146 | +2.0% | 0.00% | 0.0% |
| Q1 2018 | $4,060,000 | -1.1% | 236,365 | +26.2% | 0.00% | 0.0% |
| Q4 2017 | $4,105,000 | -45.9% | 187,297 | +1.0% | 0.00% | -50.0% |
| Q3 2017 | $7,584,000 | +41.4% | 185,382 | +4.1% | 0.00% | 0.0% |
| Q2 2017 | $5,362,000 | -19.9% | 178,088 | -3.9% | 0.00% | 0.0% |
| Q1 2017 | $6,697,000 | -14.1% | 185,266 | +19.1% | 0.00% | -33.3% |
| Q4 2016 | $7,795,000 | -5.7% | 155,565 | -1.3% | 0.00% | 0.0% |
| Q3 2016 | $8,269,000 | +36.6% | 157,545 | +7.6% | 0.00% | +50.0% |
| Q2 2016 | $6,054,000 | +1.7% | 146,434 | -0.1% | 0.00% | 0.0% |
| Q1 2016 | $5,953,000 | +23.1% | 146,545 | +25.8% | 0.00% | 0.0% |
| Q4 2015 | $4,834,000 | +164.6% | 116,488 | -1.8% | 0.00% | +100.0% |
| Q3 2015 | $1,827,000 | -50.9% | 118,667 | -20.8% | 0.00% | 0.0% |
| Q2 2015 | $3,722,000 | -24.5% | 149,850 | -30.5% | 0.00% | 0.0% |
| Q1 2015 | $4,930,000 | +39.9% | 215,686 | +65.3% | 0.00% | 0.0% |
| Q4 2014 | $3,523,000 | +94.0% | 130,455 | -15.7% | 0.00% | 0.0% |
| Q3 2014 | $1,816,000 | -23.1% | 154,812 | +2.0% | 0.00% | 0.0% |
| Q2 2014 | $2,360,000 | -22.0% | 151,733 | -1.3% | 0.00% | 0.0% |
| Q1 2014 | $3,024,000 | +297.9% | 153,796 | +239.8% | 0.00% | – |
| Q4 2013 | $760,000 | – | 45,257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|